Background: Bone morrow stem cell (BMC) transfer is an emerging therapy with potential to salvage cardiomyocytes during acute myocardial infarction and promote regeneration and endogenous repair of damaged myocardium in patients with left ventricular (LV) dysfunction. We performed a meta-analysis to examine the association between administration of BMC and LV functional recovery as assessed by imaging. Methods and Results: Our meta-analysis included data from 32 trials comprising information on 1,300 patients in the treatment arm and 1,006 patients in the control arm. Overall, BMC therapy was associated with a significant increase in LV ejection fraction by 4.6% ± 0.7% (P
CITATION STYLE
Sadat, K., Ather, S., Aljaroudi, W., Heo, J., Iskandrian, A. E., & Hage, F. G. (2014). The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. Journal of Nuclear Cardiology, 21(2), 351–367. https://doi.org/10.1007/s12350-013-9846-4
Mendeley helps you to discover research relevant for your work.